Home › Funds › M&G Plc › ABT

M&G Plc position in ABT

ABBOTT LABORATORIES · Health Care

M&G Plc reported holding 1,211,153 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$119.9M, representing 0.62% of its reported portfolio and ranking #45 among its reported holdings. M&G Plc has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.21M sh
Reported value held$119.90M
Portfolio Weight0.62%
First reportedQ3 2025
Last changeReduce
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How M&G Plc's ABT position evolved

M&G Plc first disclosed a stake in ABT in Q3 2025 at 237,694 shares (US$31.9M). The position peaked in Q2 2026 at 1,325,439 shares, worth US$120.6M. Across 5 filings, M&G Plc increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,211,153 shares valued at US$119.9M — a reduction of -114,286 shares quarter over quarter.. Notable position changes include a 45% increase in Q1 2026 (shares fell 11% over the following quarter), a 225% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 237.69K $31.85M New
Q4 2025 281.73K $35.22M Add
Q1 2026 407.78K $42.00M Add
Q2 2026 1.33M $120.61M Add
Q3 2026 1.21M $119.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has M&G Plc held ABT?

M&G Plc has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is M&G Plc's current position in ABT?

As of Q3 2026, M&G Plc holds 1.21M shares of ABT (ABBOTT LABORATORIES), valued at $119.90M, representing 0.62% of its reported portfolio and ranking #45.

Has M&G Plc been buying or selling ABT?

In the latest 13F filing (Q3 2026), M&G Plc reduced its position in ABT. The position peaked in Q2 2026 at 1.33M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.